Medwave granted two U.S., three foreign patents for blood pressure technology

By Lisa Kerner

Charlotte, N.C., July 12 - Medwave, Inc. said it has been granted two new U.S. patents and three new foreign patents over the past nine months, bringing its U.S. patent total to 27 granted patents and the total number of foreign patents granted to 11.

Seven additional U.S. patents and four foreign patents are pending.

"We believe Medwave's sensor-based, non-invasive blood pressure measurement technology is not only the sensible alternative to the antiquated cuff technology, but the quintessential modern solution, therefore we have been deliberate and strategic in our approach to our intellectual property position," president and chief executive officer Tim O'Malley said in a company news release.

Located in Danvers, Mass., Medwave develops, manufactures and distributes sensor-based non-invasive blood pressure solutions.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.